公开(公告)号：US20230272105A1

公开(公告)日：2023-08-31

申请号：US17792268

申请日：2021-01-15

Applicant: GENMAB A/S

Inventor： Jacob D. CLAUSEN ,  Richard HIBBERT ,  Michael B. DALGAARD

IPC: C07K16/28 ,  A61K47/22 ,  A61K47/12 ,  A61K47/26

CPC classification number: C07K16/2896 ,  A61K47/22 ,  A61K47/12 ,  A61K47/26 ,  C07K2317/35 ,  C07K2317/92 ,  C07K2317/76 ,  C07K2317/73

Abstract: The present invention provides pharmaceutical formulations comprising antibodies binding to CD38 and to the use of said formulations in the treatment of cancer and other indications.